Polymeric synthetic antidote
US-2016193246-A1 · Jul 7, 2016 · US
US12433910B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12433910-B2 |
| Application number | US-202418816696-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 27, 2024 |
| Priority date | Dec 3, 2020 |
| Publication date | Oct 7, 2025 |
| Grant date | Oct 7, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to polymer nanoparticle and DNA nanostructure delivery compositions for non-viral delivery, and methods therefor. More particularly, the invention relates to polymer nanoparticle delivery compositions, such as reversible addition-fragmentation chain transfer (RAFT) polymer compositions, and DNA nanostructure delivery compositions, such as DNA origami compositions, for the delivery of more than one payload, or for the delivery of a nucleic acid construct payload of 3 kB or more, and methods therefor.
Opening claim text (preview).
What is claimed is: 1. A composition comprising a polymer nanoparticle and a payload, wherein the polymer nanoparticle comprises a RAFT block copolymer that comprises: a first block prepared from one or more monomer units, and having a molecular weight (M n ) in the range of about 20 kDa to about 80 kDa and a degree of polymerization in the range of about 20 to about 400; a second block prepared from one or more monomer units covalently attached to the first block, and having a molecular weight (M n ) in the range of about 5 kDa to about 80 kDa and a degree of polymerization in the range of about 10 to about 500; and wherein the RAFT block copolymer has one or more of an overall molecular weight (M n ) in the range of about 25 kDa to about 160 kDa, and overall degree of polymerization in the range of about 30 to about 900, and wherein the payload comprises a nucleic acid. 2. The composition of claim 1 , wherein the payload is chemically bonded to the polymer nanoparticle. 3. The composition of claim 1 , wherein the payload is complexed with the polymer nanoparticle. 4. The composition of claim 3 , wherein the payload is complexed with the polymer nanoparticle through electrostatic interactions. 5. The composition of claim 1 , wherein the polymer nanoparticle has a size in the range of about of about 10 to about 60 nm. 6. The composition of claim 1 , wherein the first block is prepared from one or more monomer units selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 7. The composition of claim 6 , wherein the second block is prepared from one or more monomer units selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 8. The composition of claim 6 , wherein the second block is a random copolymer prepared from two different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 9. The composition of claim 6 , wherein the second block is a random copolymer prepared from three different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 10. The composition of claim 1 , wherein the first block is prepared from one of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, or methyl methacrylate. 11. The composition of claim 10 , wherein the second block is prepared from one or more monomer units selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 12. The composition of claim 10 , wherein the second block is a random copolymer prepared from two different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 13. The composition of claim 10 , wherein the second block is a random copolymer prepared from three different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 14. The composition of claim 1 , wherein the second block is prepared from one or more monomer units selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 15. The composition of claim 1 , wherein the second block is a random copolymer prepared from two different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 16. The composition of claim 1 , wherein the second block is a random copolymer prepared from three different monomer units independently selected from the group consisting of 2-dimethylaminoethyl acrylate, 2-(diethylamino) ethyl methacrylate, 2-(diisopropylamino) ethyl methacrylate, butyl methacrylate, ethyl acrylic acid, propyl acrylic acid, (hydroxyethyl) methacrylate, and methyl methacrylate. 17. The composition of claim 1 , wherein the first block comprises a first capping unit of the formula wherein * represents a point of covalent attachment to the first block. 18. The composition of claim 1 , wherein the second block comprises a second capping unit of the formula wherein * represents a point of covalent attachment to the second block, and R is-SC 2 -C 12 alkyl or C 6 H 5 . 19. The composition of claim 1 , wherein the nucleic acid is a DNA or an RNA. 20. The composition of claim 19 , wherein the nucleic acid is complexed with the polymer nanoparticle through electrostatic interactions. 21. The composition of claim 19 , wherein the nucleic acid is a DNA. 22. The composition of claim 21 , wherein the DNA is complexed with the polymer nanoparticle through electrostatic interactions. 23. The composition of claim 19 , wherein the nucleic acid is an RNA. 24. The composition of claim 23 , wherein the RNA is complexed with the polymer nanoparticle through electrostatic interactions. 25. The composition of claim 19 , wherein the nucleic acid has a size of 3 kB-kB or more. 26. The composition of claim 19 , wherein the nucleic acid has size of 6.5 kB or more. 27. The composition of claim 19 , wherein the nucleic acid has a size of 8.5 kB or more. 28. The composition of claim 1 , wherein the payload comprises one or more of the components of the CRISPR RNP system. 29. The composition of claim 28 , wherein the one or more of the components of the CRISPR RNP system includes a CRISPR-associated enzyme, a short guide RNA (sgRNA), and a donor DNA strand. 30. The composition of claim 29 , wherein the CRISPR-associated enzyme i
Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX] · CPC title
using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Antisense · CPC title
Methods or apparatus for measurement or analysis of nanostructures · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.